FindTrial
Sign In

Study on the Role and Mechanism of PPP3CA-NFATc1 Glycolysis Pathway in Resisting Copper Death and Promoting the Proliferation of Intrahepatic Cholangiocarcinoma

Study on the Role and Mechanism of PPP3CA-NFATc1 Glycolysis Pathway in Resisting Copper Death and Promoting the Proliferation of Intrahepatic Cholangiocarcinoma

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500110523
Enrollment
Unknown
Registered
2025-10-15
Start date
2023-12-06
Completion date
Unknown
Last updated
2025-10-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cholangiocarcinoma

Interventions

Cancer group and adjacent cancer group:None

Sponsors

Ningbo University Affiliated First Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Pathologically confirmed cholangiocarcinoma patients;

Exclusion criteria

Exclusion criteria: 1. Acute inflammatory phase; 2. Coagulation dysfunction

Design outcomes

Primary

MeasureTime frame
PPP3CA;—

Secondary

MeasureTime frame
NFAT1c;—

Countries

China

Contacts

Public ContactXu Liping

Ningbo University Affiliated First Hospital

22434289@qq.com+86 574 8755 9764

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026